September 8, 2017Open Access

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM)

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

EBV treatment in hyperinflated patients with heterogeneous emphysema without collateral ventilation resulted in clinically meaningful benefits in lung function, dyspnea, exercise tolerance, and quality of life, with an acceptable safety profile. Clinical trial registered with www.clinicaltrials.gov (NCT02022683).

Me gusta

Guardar

Ver artículo completo

Cite This Study

Kemp et al. (Fri,) studied this question.

synapsesocial.com/papers/69d94c4bc7f0c3ae80a3caa3 https://doi.org/https://doi.org/10.1164/rccm.201707-1327oc

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial2016 · 61 citations
2Expert Statement: Pneumothorax Associated with Endoscopic Valve Therapy for Emphysema - Potential Mechanisms, Treatment Algorithm, and Case Examples2014 · 118 citations
3Lung Volume Reduction Surgery vs Medical Treatment<sup>*</sup>2005 · 38 citations
4Burden of chronic obstructive pulmonary disease: Healthcare costs and beyond2014 · 298 citations
5A sharper Bonferroni procedure for multiple tests of significance1988 · 4,741 citations

Me gusta

Guardar

Ver artículo completo